• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Is it Time for a Federal "Vaccines for Adults" Program?

Slideshow

Would a program for US adults who are uninsured or underinsured help increase uptake rates for recommended immunizatons, for example, against influenza and pneumococcal disease? Would it make economic sense?

Terry Brenneman, MD
Terry Brenneman, MD

I read a June 21, 2023 Perspective feature in the New England Journal of Medicine written by scientists from the Centers for Disease Control and Prevention and the the National Center for Immunization and Respiratory Diseases that answers the question comprehensively and clearly. This short slide show-plus-quiz-questions higlights their thoughts. A hyperlink to the full article is below.

Wallender E, Peacock G, Wharton M, Walensky RP. Uninsured and not immune--closing the vaccine-coverage gap for adults. N Engl J Med. Published online June 21, 2023. doi:10.1056/NEJMp2306200

Related Videos
Infectious disease specialist talks about COVID-19 vaccine development
COVID 19 impact on healthcare provider mental health
Physician mental health expert discusses impact of COVID-19 on health care workers
Related Content
Tsuboya

ACIP Recommends 2nd COVID-19 Shot for Older Adults, Immunocompromised Individuals

Sydney Jennings
October 24th 2024
Article

CDC Director Mandy Cohen endorsed the ACIP's recommendations, which also call for flexible dosing under shared clinical decision making.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

FDA Expands Indication for RSV Vaccine Abrysvo to Include Adults Aged 18 to 59 with Chronic Conditions

FDA Expands Indication for RSV Vaccine Abrysvo to Include Adults Aged 18 to 59 with Chronic Conditions

Grace Halsey
October 23rd 2024
Article

Pfizer announced the FDA approval on October 22 that makes Abrysvo now the RSV immunization with the broadest indication for adults, the company said.

Primary Viewpoints Episode 11: AAFP President-elect Discusses Greatest Concerns about Upcoming Flu Season

Primary Viewpoints Episode 11: AAFP President-elect Discusses Greatest Concerns about Upcoming Flu Season

Sydney Jennings
September 13th 2021
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with incoming AAFP president Sterling Ransone, MD.

The Legacy of Vaccine Hesitancy: From COVID-19 to Flu

The Legacy of Vaccine Hesitancy: From COVID-19 to Flu

October 22nd 2024
Article

Vaccine hesitancy became a public health threat during the COVID-19 pandemic that lingers now and has affected uptake of other essential immunizations.

Pfizer-BioNTech COVID-19 Vaccine May Reduce Risk of Long COVID in Older Adults / Image credit: ©Tobias Arhelger/AdobeStock

Pfizer-BioNTech COVID-19 Vaccine May Reduce Risk of Long COVID in Older Adults

Sydney Jennings
October 21st 2024
Article

IDWeek 2024: Older adults vaccinated with BNT162b2 (Comirnaty) had approximately half the odds of developing long COVID vs unvaccinated adults, according to new data.

© 2024 MJH Life Sciences

All rights reserved.